日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer

HER2DX基因组检测与HER2阳性乳腺癌生物学和病理特征的关联

Sanfeliu, Esther; Martínez-Romero, Anabel; Marín-Aguilera, Mercedes; Cobo, Sandra; González-Farré, Blanca; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butillé, Joan Antón; Muñoz, Montserrat; Gómez-Bravo, Raquel; Tapia, Marta; Tebar, Cristina; Saura, Cristina; Escrivà-de-Romaní, Santiago; Soberino, Jesús; Cortés, Javier; Morales, Serafin; Amillano, Kepa; Paré, Laia; Villagrasa, Patricia; Buckingham, Wesley; Pardo, Francisco; Parker, Joel S; Brasó-Maristany, Fara; Ciruelos, Eva; Sánchez-Bayona, Rodrigo; Martinez-Sáez, Olga; Cejalvo, Juan Miguel; Prat, Aleix

Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial

雌激素受体阳性、HER2阴性早期乳腺癌女性患者接受Elacestrant治疗:术前治疗窗口期ELIPSE试验结果

Vidal, Maria; Falato, Claudette; Pascual, Tomás; Sanchez-Bayona, Rodrigo; Muñoz-Mateu, Montserrat; Cebrecos, Isaac; Gonzalez-Farré, Xavier; Cortadellas, Tomás; Margelí Vila, Mireia; Luna, Miguel A; Siso, Christian; Amillano, Kepa; Galván, Patricia; Bergamino, Milana A; Ferrero-Cafiero, Juan M; Salvador, Fernando; Espinosa Guerrero, Alejandra; Pare, Laia; Sanfeliu, Esther; Prat, Aleix; Bellet, Meritxell

Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial

在PARSIFAL试验中,对帕博西尼联合氟维司群或来曲唑治疗内分泌敏感、激素受体阳性/HER2阴性晚期乳腺癌患者进行了延长随访。

Llombart-Cussac, A; Pérez-García, J M; Bellet, M; Dalenc, F; Gil-Gil, M; Ruiz-Borrego, M; Gavila, J; Schmid, P; Zamora, P; Wheatley, D; Martínez-de Dueñas, E; Amillano, K; Di Cosimo, S; Anton, A; Cottu, P; Shimizu, E; Fernandez, M; Sampayo-Cordero, M; Cortés, J

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial

抗PD-1疗法在多种癌症类型中PD-1高表达mRNA肿瘤中的疗效:SOLTI-1904 ACROPOLI II期试验队列1和队列2的结果

Seguí, E; Brasó-Maristany, F; Pascual, T; Sanfeliu, E; Victoria, I; Saura, C; Hierro, C; López-González, A; Izarzugaza, Y; Ciruelos, E; Gavilá, J; Racca, F; Cejalvo, J M; Amillano, K; Paz-Ares, L; Juan, M; Felip, E; Garralda, E; González, B; Arance, A; Martín-Liberal, J; Conte, B; Walbaum, B; Indacochea, A; Castillo, O; Blasco, P; Pardo, F; Aguirre, Á; Sirenko, V; González, X; Galván, P; Vivancos, A; Ferrero-Cafiero, J M; Mulero-Sánchez, A; Salvador, F; Villacampa, G; Mesía, R; Cervantes, A; Prat, A; Tabernero, J

Effects of Microorganisms in Fish Aquaculture from a Sustainable Approach: A Review

从可持续的角度探讨微生物在鱼类养殖中的作用:综述

Amillano-Cisneros, Jesús Mateo; Fuentes-Valencia, María Anel; Leyva-Morales, José Belisario; Savín-Amador, Macario; Márquez-Pacheco, Henri; Bastidas-Bastidas, Pedro de Jesús; Leyva-Camacho, Lucía; De la Torre-Espinosa, Zamaria Yoselin; Badilla-Medina, César Noé

Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial

帕博西尼联合氟维司群或来曲唑治疗内分泌敏感的HR阳性/HER2阴性晚期乳腺癌患者:PARSIFAL随机试验的详细安全性分析

Di Cosimo, Serena; Pérez-García, José Manuel; Bellet, Meritxell; Dalenc, Florence; Gil Gil, Miguel J; Ruiz Borrego, Manuel; Gavilá, Joaquín; Sampayo-Cordero, Miguel; Aguirre, Elena; Schmid, Peter; Marmé, Frederik; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; Martínez-De Dueñas, Eduardo; Carañana, Vicente; Amillano, Kepa; Mina, Leonardo; Malfettone, Andrea; Cortés, Javier; Llombart-Cussac, Antonio

Prebiotics in Global and Mexican Fish Aquaculture: A Review

全球及墨西哥鱼类养殖中的益生元:综述

Amillano-Cisneros, Jesús Mateo; Fuentes-Valencia, María Anel; Leyva-Morales, José Belisario; Davizón, Yasser A; Marquéz-Pacheco, Henri; Valencia-Castañeda, Gladys; Maldonado-Coyac, Juan Antonio; Ontiveros-García, Luz Adriana; Badilla-Medina, Cesar Noé

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

帕博西尼辅助治疗早期乳腺癌:PALLAS试验结果(ABCSG-42/AFT-05/BIG-14-03)

Gnant, Michael; Dueck, Amylou C; Frantal, Sophie; Martin, Miguel; Burstein, Hal J; Greil, Richard; Fox, Peter; Wolff, Antonio C; Chan, Arlene; Winer, Eric P; Pfeiler, Georg; Miller, Kathy D; Colleoni, Marco; Suga, Jennifer M; Rubovsky, Gabor; Bliss, Judith M; Mayer, Ingrid A; Singer, Christian F; Nowecki, Zbigniew; Hahn, Olwen; Thomson, Jacqui; Wolmark, Norman; Amillano, Kepa; Rugo, Hope S; Steger, Guenther G; Hernando Fernández de Aránguiz, Blanca; Haddad, Tufia C; Perelló, Antonia; Bellet, Meritxell; Fohler, Hannes; Metzger Filho, Otto; Jallitsch-Halper, Anita; Solomon, Kadine; Schurmans, Céline; Theall, Kathy P; Lu, Dongrui R; Tenner, Kathleen; Fesl, Christian; DeMichele, Angela; Mayer, Erica L

Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical Trial

氟维司群-帕博西尼对比来曲唑-帕博西尼作为内分泌敏感、激素受体阳性、ERBB2阴性晚期乳腺癌一线治疗:一项随机临床试验

Llombart-Cussac, Antonio; Pérez-García, José Manuel; Bellet, Meritxell; Dalenc, Florence; Gil-Gil, Miguel; Ruíz-Borrego, Manuel; Gavilá, Joaquín; Sampayo-Cordero, Miguel; Aguirre, Elena; Schmid, Peter; Marmé, Frederik; Di Cosimo, Serena; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; Martínez-de Dueñas, Eduardo; Amillano, Kepa; Malfettone, Andrea; Cortés, Javier

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

新辅助艾立布林治疗HER2阴性早期乳腺癌(SOLTI-1007-NeoEribulin):一项多中心、双队列、非随机II期试验

Pascual, Tomás; Oliveira, Mafalda; Villagrasa, Patricia; Ortega, Vanesa; Paré, Laia; Bermejo, Begoña; Morales, Serafín; Amillano, Kepa; López, Rafael; Galván, Patricia; Canes, Jordi; Salvador, Fernando; Nuciforo, Paolo; Rubio, Isabel T; Llombart-Cussac, Antonio; Di Cosimo, Serena; Baselga, José; Harbeck, Nadia; Prat, Aleix; Cortés, Javier